![Ehong Gu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/08/2026
Ehong Gu is currently the Chief Financial & Accounting Officer at LianBio.
Previously, she worked as the Assistant Vice President-Finance at CStone Pharmaceuticals Co. Ltd. from 2019 to 2021.
She holds an MBA from Rotman School of Management and an undergraduate degree from Shanghai University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LIANBIO -.--% | 19/12/2023 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LIANMEDICAL | Director Financiero/CFO | 19/12/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| CSTONE PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University
 Shanghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
